Načítá se...
DNA Damage Response in Prostate Cancer
Prostatic adenocarcinoma (PCa) remains a significant health concern. Although localized PCa can be effectively treated, disseminated disease remains uniformly fatal. PCa is reliant on androgen receptor (AR); as such, first-line therapy for metastatic PCa entails suppression of AR signaling. Although...
Uloženo v:
| Vydáno v: | Cold Spring Harb Perspect Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cold Spring Harbor Laboratory Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6314076/ https://ncbi.nlm.nih.gov/pubmed/29530944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a030486 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|